Shares
 
FAQs

Visit our FAQ page to find the answers to the most commonly asked questions, including how to create an account, explaining ETFs, and providing useful links, forms, and tables.

FAQs
Shares

Start investing in Australian shares the smart way. Discover ThinkTrader today.

Open Shares Account
Learn To Trade
 
Indicators & Chart Patterns

Deepen your knowledge of technical analysis indicators and hone your skills as a trader.

Find your detailed guides here
Trading Glossary

From beginners to experts, all traders need to know a wide range of technical terms. Let us be your guide.

Learn more
Knowledge Base

No matter your experience level, download our free trading guides and develop your skills.

Learn more
Learn To Trade

Trade smarter: boost your skills with our training resources.

Create a live account
Market Analysis
 
Market News

All the latest market news, with regular insights and analysis from our in-house experts

Learn more
Economic Calendar

Make sure you are ahead of every market move with our constantly updated economic calendar.

Learn more
Technical Analysis

Harness past market data to forecast price direction and anticipate market moves.

Learn more
Live Webinars

Boost your investing knowledge with our live, interactive webinars delivered by industry experts.

Register now
Special Reports

Engaging, in-depth macroeconomic analysis and expert educational content from our in-house analysts

Learn more
Market Analysis

Harness the market intelligence you need to build your trading strategies.

Create a live account
Partnership
 
Money Manager

Increase your income and get compensated for your trading knowledge with ThinkInvest, putting you in control.

Learn more
Introducing Broker

ThinkMarkets ensures high levels of client satisfaction with high client retention and conversion rates.

Learn more
White Label

We supply everything you need to create your own brand in the Forex industry.

Learn more
Regional Representatives

Partner with ThinkMarkets today to access full consulting services, promotional materials and your own budgets.

Learn more
Partnership

Plug into the next-gen platforms and the trades your clients want.

 
About ThinkMarkets
 
Sponsorships

Check out our sponsorships with global institutions and athletes, built on shared values of excellence.

Learn more
About Us

Find out more about ThinkMarkets, an established, multi-award winning global broker you can trust.

Learn more
Negative Balance Protection

Trade with peace of mind. Never lose more than what you deposited, no matter what the market conditions.

Learn more
Careers

Discover a range of rewarding career possibilities across the globe

Apply now
ThinkMarkets News

Keep up to date with our latest company news and announcements

Learn more
Trading Infrastructure

When it comes to the speed we execute your trades, no expense is spared. Find out more.

Learn more
Contact Us

Our multilingual support team is here for you 24/7.

Learn more
About ThinkMarkets

Global presence, local expertise - find out what sets us apart.

Create a live account
Log in Create account

Fears over efficacy of vaccines against Omicron grow

Fawad Razaqzada Fawad Razaqzada 30/11/2021
Fears over efficacy of vaccines against Omicron grow Fears over efficacy of vaccines against Omicron grow
Fears over efficacy of vaccines against Omicron grow Fawad Razaqzada
Well, it feels like 2020 all over again. After rebounding sharply off their lows yesterday, US futures are sharply lower after Asian and European markets slumped overnight. Crude oil has retested the lows it had hit on Friday when prices slumped by $10. Sentiment is downbeat as fears over the efficacy of the Covid vaccines against the latest variant of the virus have intensified. Comments from the Moderna boss has cast doubt over whether existing vaccines would be able to work on omicron. If they are not effective, then it probably means more economic growth-choking restrictions and lockdowns until scientists find new vaccines.
 
Judging by the market’s wild swings, it is clears that more in-depth assessment of the new Covid variant needs to be carried out, before determining whether the economy is facing a major challenge in the coming months. Yesterday, investors assumed that Omicron may not be as bad as had been feared on Friday, and that vaccines may still prove effective. But that thesis has been tested and investors fear they may have got it all wrong, for otherwise the markets wouldn’t have fallen this much. It will take some time to understand this variant better, given how little is known about it. So, get used to this sort of volatility as investors continually take profit and buy the dips here and there, until there’s more clarity on the virus front, while also keeping a close eye on other macro developments. Expect choppy price action to continue over the next few weeks.
 
With Covid weighing on investor sentiment, investors are pricing out rate hikes from central banks that have become hawkish recently amid inflation upsurge, such as the Federal Reserve. Jerome Powell, the US central bank’s chairman will be talking later today. Investors have been piling back into US debt and out of the dollar in favour of the euro and yen etc. Powell may provide some insight into how the latest worries about the pandemic might influence monetary policy in the US. The key question is whether the Fed would still go ahead and taper its bond buying programme at a faster rate? The markets certainly don’t think so.
 
 
It is becoming clear that the market’s direction has now tilted to a more risk-off path. This means that we will likely see resistance levels holding firm after short term recoveries, while support levels are likely to break down one after another until something fundamentally changes. Pay attention to whether bullish signals will lead to any upside follow-through, or whether they prove to be traps and fail the bulls. Judging to the price action over the past couple of days, it is clear the bulls are becoming trapped. So, proceed with extra care until the markets print decisive bottoming formations.

marketsSource: ThinkMarkets and TradingView.com
Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.

Related articles:

Weekly Index Dividends

By ThinkMarkets

25/03/2024

Weekly Index Dividends

By ThinkMarkets

18/03/2024

Weekly Index Dividends

By ThinkMarkets

11/03/2024

Weekly Index Dividends

By ThinkMarkets

04/03/2024

Weekly Index Dividends

By ThinkMarkets

26/02/2024

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.
Back to top